Chlorzoxazone
From Wikipedia, the free encyclopedia
Chlorzoxazone
|
|
Systematic (IUPAC) name | |
5-chloro-3H-benzooxazol-2-one | |
Identifiers | |
CAS number | |
ATC code | M03 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C7H4ClNO2 |
Mol. mass | 169.565 g/mol |
SMILES | & |
Pharmacokinetic data | |
Bioavailability | well absorbed |
Protein binding | 13–18% |
Metabolism | hepatic |
Half life | 1.1 hr |
Excretion | urine (<1%) |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | oral |
Chlorzoxazone is a centrally acting muscle relaxant used to treat muscle spasm and the resulting pain or discomfort. It acts on the spinal cord by depressing reflexes. It is sold as Parafon Forte, a combination of chlorzoxazone and acetaminophen. Possible side effects include dizziness, lightheadedness, malaise, nausea, vomiting, and liver dysfunction.
[edit] External links
- Dong DL, Luan Y, Feng TM, Fan CL, Yue P, Sun ZJ, Gu RM, Yang BF. (2006). "Chlorzoxazone inhibit contraction of rat thoracic aorta.". Eur J Pharmacol. doi: . PMID 16859676.
- Park J, Kim K, Park P, Ha J (2006). "Effect of high-dose aspirin on CYP2E1 activity in healthy subjects measured using chlorzoxazone as a probe.". J Clin Pharmacol 46 (1): 109–14. doi: . PMID 16397290.
- Wan J, Ernstgård L, Song B, Shoaf S (2006). "Chlorzoxazone metabolism is increased in fasted Sprague-Dawley rats.". J Pharm Pharmacol 58 (1): 51–61. doi: . PMID 16393464.
|